82 related articles for article (PubMed ID: 21029606)
1. [Research of the characterization of Bcrp1(+) HeLa cells].
Zhang SL; Yu XW; Wei ZT; Fu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):525-9. PubMed ID: 21029606
[TBL] [Abstract][Full Text] [Related]
2. [Study of the invasiveness and tumour formation of Bcrp1(+) HeLa cervical cancer cells].
Zhang SL; Yu XW; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):526-9. PubMed ID: 23141165
[TBL] [Abstract][Full Text] [Related]
3. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
Ho MM; Hogge DE; Ling V
Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
[TBL] [Abstract][Full Text] [Related]
4. [Study of mechanism of medroxyprogesterone 17-acetate on the cancer stem cell-like properties of human endometrial cancer].
Liu BJ; Li XP; Zhao LJ; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):772-7. PubMed ID: 24406136
[TBL] [Abstract][Full Text] [Related]
5. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
6. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
8. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo.
Zhou S; Morris JJ; Barnes Y; Lan L; Schuetz JD; Sorrentino BP
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12339-44. PubMed ID: 12218177
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
11. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1.
Shimano K; Satake M; Okaya A; Kitanaka J; Kitanaka N; Takemura M; Sakagami M; Terada N; Tsujimura T
Am J Pathol; 2003 Jul; 163(1):3-9. PubMed ID: 12819005
[TBL] [Abstract][Full Text] [Related]
12. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
van Herwaarden AE; Jonker JW; Wagenaar E; Brinkhuis RF; Schellens JH; Beijnen JH; Schinkel AH
Cancer Res; 2003 Oct; 63(19):6447-52. PubMed ID: 14559835
[TBL] [Abstract][Full Text] [Related]
13. The ATP-binding cassette transporter BCRP1/ABCG2 plays a pivotal role in cardiac repair after myocardial infarction via modulation of microvascular endothelial cell survival and function.
Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Sahara M; Tanaka K; Koibuchi N; Ito S; Kusuhara H; Sugiyama Y; Hirata Y; Nagai R; Sata M
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2128-35. PubMed ID: 20829509
[TBL] [Abstract][Full Text] [Related]
14. Side population cells and Bcrp1 expression in lung.
Summer R; Kotton DN; Sun X; Ma B; Fitzsimmons K; Fine A
Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L97-104. PubMed ID: 12626330
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.
Budak MT; Alpdogan OS; Zhou M; Lavker RM; Akinci MA; Wolosin JM
J Cell Sci; 2005 Apr; 118(Pt 8):1715-24. PubMed ID: 15811951
[TBL] [Abstract][Full Text] [Related]
16. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
[TBL] [Abstract][Full Text] [Related]
17. [Effect and mechanism of an autophagy gene beclin 1 on cervical cancer HeLa cells].
Wang ZH; Li L; Duan ZL
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):125-31. PubMed ID: 21426771
[TBL] [Abstract][Full Text] [Related]
18. [Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].
Qu HB; Fan YM; Han ML; Luo HJ; Xie J; Liu H; Liu H; Wu CY; Tang WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):171-6. PubMed ID: 23643006
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis and expressions of PDCD5 and Caspase-3 in renal tissues of children with lupus nephritis].
Li X; Huang JP; Ding J
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):517-20. PubMed ID: 16083554
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
